AstaTech, Inc.

AstaTech, Inc. is a US based CRO/CMO specializing in advanced intermediates, custom synthesis, and FTE from lab scale to mass production. Founded in 1996 by former scientists from leading pharmaceutical companies, AstaTech is one of the earliest chemistry CRO companies in the United States. With over 100 chemists, 40% holding PH.D or MS degrees, the company serves 10,000 customers worldwide. It offers over 100,000 advanced intermediates and drug-like building blocks, with 10% of its products being scalable to kg/MT scales. AstaTech's expertise and manufacturing capabilities enable it to deliver high-quality chemistry solutions from drug discovery to manufacturing at competitive costs. The latest investment of CNY200.00M in a Series B round took place on 29 July 2022 and was led by Shenyin & Wanguo Investment.